Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy
CANTIN, G, L'ESPERANCE, B, HEWITT, L. A, PIRC, L, GYGER, M, YELLE, L, DESJARDINS, L, COUTURE, F, BERGERON, M, LACROIX, L, DUFRESNE, J, BELANGER, D, OUELLET, P. A
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article